GO:0046477 glycosylceramide catabolic process: Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046477 (glycosylceramide catabolic process) describes the biochemical breakdown of glycosylceramides, compounds formed when a monosaccharide is linked to a ceramide group.
• Glycosylceramides are central intermediates of sphingolipid metabolism in fungi, plants, and animals, and their catabolism feeds ceramide and sphingoid-base pools that control stress and redox signaling.
• In yeast, glycosylceramide remodeling is required for normal sphingolipid homeostasis and influences fermentation traits such as flavor and metabolic output.
• Dietary and microbial glycosylceramides can alter host cholesterol metabolism, linking this catabolic process to metabolic disease research.
• Altered sphingolipid catabolism, including glycosylceramide turnover, is implicated in neurodegeneration and cardiovascular outcomes through ceramide-driven redox changes.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are the standard tools for dissecting glycosylceramide catabolic enzymes and their disease relevance.
Description
GO:0046477, glycosylceramide catabolic process, is the biological process by which glycosylceramides are chemically broken down. Glycosylceramides are sphingolipids in which the glycosidic hydroxyl group of a cyclic monosaccharide, or a derivative of it, is replaced by a ceramide group. This definition places the term at the intersection of carbohydrate and lipid metabolism, and it is used in annotation of enzymes and pathways that release ceramide and sugar moieties from glycosylated sphingolipids. Because glycosylceramides are abundant in fungi, plants, and some marine organisms, the catabolic process is studied across diverse experimental systems, from sake yeast to Physcomitrium patens and microalgae. For researchers, GO:0046477 matters because the products of glycosylceramide breakdown, particularly ceramides and sphingoid bases, are potent bioactive lipids. Ceramides regulate vascular redox state and are associated with cardiovascular outcomes in patients, while sphingolipid signaling broadly influences redox regulation and cell stress responses. In the nervous system, ceramide and sphingosine-1-phosphate balance is linked to neurodegeneration. Thus, the catabolic process is not merely a degradative endpoint but a control point that determines the availability of signaling lipids. Experimental work on glycosylceramide catabolism spans microbial genetics, plant lipid biology, and mammalian disease models. Yeast studies show that glycosylceramide composition modifies flavor and metabolic characteristics, and koji glycosylceramide from traditional fermented foods alters cholesterol metabolism in obese mice. In plants, sphingolipid desaturation is an important step for glycosylceramide formation, highlighting the interplay between biosynthetic and catabolic routes. These findings make GO:0046477 a practical annotation target for functional genomics, metabolic engineering, and disease mechanism studies.
glycosylceramide catabolic process At A Glance
| GO ID | GO:0046477 |
|---|---|
| GO term | glycosylceramide catabolic process |
| Ontology | biological_process |
| Synonym | glycosylceramide breakdown; glycosylceramide catabolism; glycosylceramide degradation |
| Definition | The chemical reactions and pathways resulting in the breakdown of glycosylceramides, any compound formed by the replacement of the glycosidic hydroxyl group of a cyclic form of a monosaccharide (or derivative) by a ceramide group. |
| Major function | Degradation of glycosylated ceramides to release ceramide, sphingoid bases, and sugar moieties for recycling and signaling. |
| Organisms studied | Yeast, plants such as Physcomitrium patens, microalgae, and mammals. |
| Related lipids | Ceramide, sphingosine-1-phosphate, and other sphingolipid intermediates. |
| Disease relevance | Cardiovascular disease, neurodegeneration, and metabolic disorders linked to sphingolipid imbalance. |
What Is GO:0046477?
In plain terms, GO:0046477 describes the set of reactions that dismantle glycosylceramides, which are ceramides carrying a sugar group. The QuickGO definition states that this process comprises the chemical reactions and pathways resulting in the breakdown of glycosylceramides, defined as any compound formed by replacement of the glycosidic hydroxyl group of a cyclic form of a monosaccharide (or derivative) by a ceramide group. The term is a child of sphingolipid catabolic process and is synonymous with glycosylceramide breakdown, glycosylceramide catabolism, and glycosylceramide degradation. It covers enzymatic hydrolysis and related reactions that liberate ceramide, sphingoid bases, and sugar-derived products, thereby feeding them back into cellular lipid pools.
Why Is glycosylceramide catabolic process Important in Cell Biology?
Glycosylceramide catabolic process is important because it controls the cellular balance between complex glycosphingolipids and bioactive ceramides. Ceramides released by this process influence vascular redox state and are associated with adverse cardiovascular outcomes in patients. Sphingolipid signaling, including ceramide and sphingosine-1-phosphate, regulates redox homeostasis and stress responses. In the nervous system, dysregulated ceramide metabolism is linked to neurodegeneration. In addition, glycosylceramides from dietary and microbial sources can modify host cholesterol metabolism, connecting this catabolic pathway to metabolic disease. Therefore, GO:0046477 is a key annotation for understanding lipid signaling, membrane homeostasis, and disease mechanisms.
• Controls release of ceramide, a bioactive lipid that regulates vascular redox state and cardiovascular outcomes.
• Maintains sphingolipid homeostasis by recycling ceramide and sugar moieties.
• Modulates redox regulation and cell stress through sphingolipid signaling.
• Influences fermentation traits and metabolic characteristics in yeast.
• Links dietary glycosylceramides to cholesterol metabolism in obese mice.
• Interacts with sphingolipid desaturation pathways in plants.
• Contributes to ceramide and S1P balance relevant to neurodegeneration.
• Provides a target for metabolic engineering of sphingolipid-derived products.
• Offers biomarkers and therapeutic hypotheses for cardiovascular and metabolic disease.
• Enables functional annotation of glycosidases and lipid hydrolases in genome studies.
What Happens During glycosylceramide catabolic process?
Substrate recognition and glycosidic bond cleavage
In simple terms: The first step is recognizing the sugar attached to ceramide and cutting it off.
Glycosylceramide catabolic process begins with recognition of the glycosidic linkage between the monosaccharide and the ceramide moiety. The QuickGO definition specifies that glycosylceramides are formed by replacement of the glycosidic hydroxyl group of a cyclic monosaccharide by a ceramide group, so catabolism reverses this linkage. Enzymatic hydrolysis releases free ceramide and a sugar or sugar derivative, feeding both into downstream metabolic pools. In yeast, the balance of glycosylceramide species is sensitive to sphingolipid pathway flux, indicating that cleavage is integrated with broader sphingolipid metabolism.
Release of ceramide and sphingoid bases
In simple terms: Breaking down glycosylceramide produces ceramide and related lipids that cells can reuse or signal with.
The products of glycosylceramide breakdown include ceramide and, after further hydrolysis, sphingoid bases. These lipids are not inert waste; ceramides regulate vascular redox state and are associated with cardiovascular outcomes. Sphingolipid signaling involving ceramide and sphingosine-1-phosphate controls redox regulation and stress responses. Thus, the catabolic process directly supplies bioactive lipids that influence cell fate and physiology.
Recycling into sphingolipid biosynthesis
In simple terms: The breakdown products can be reused to build new sphingolipids.
Catabolic intermediates generated from glycosylceramides can re-enter biosynthetic pathways. In Physcomitrium patens, sphingolipid delta-4 desaturation is an important metabolic step for glycosylceramide formation, showing that formation and breakdown are metabolically connected. In yeast, sphingolipid metabolism is highly dynamic and required for normal growth and stress resistance. This recycling supports membrane homeostasis and allows cells to remodel sphingolipid composition in response to environmental cues.
Integration with redox and stress signaling
In simple terms: The lipids released by this process can change how cells handle oxidative stress.
Sphingolipid signaling and redox regulation are closely linked, with ceramide and related lipids influencing oxidative stress pathways. Ceramides secreted from fat tissue regulate vascular redox state and influence outcomes in patients with cardiovascular disease. In neurodegeneration, ceramide and S1P balance is a key determinant of neuronal stress responses. Therefore, glycosylceramide catabolic process is mechanistically coupled to redox and stress signaling networks.
Dietary and microbial glycosylceramide turnover
In simple terms: Glycosylceramides from food and microbes are processed by catabolic enzymes in the gut and host.
Glycosylceramides are present in traditional fermented foods, and koji glycosylceramide alters cholesterol metabolism in obese mice. Sake yeast glycosylceramide modifies flavor and metabolic characteristics, indicating that catabolic and compositional changes in yeast affect food properties. Marine microalgae also produce sterol and sphingoid glycoconjugates, expanding the range of organisms in which glycosylceramide-related metabolism is studied. These findings connect GO:0046477 to nutrition, microbiome, and metabolic disease research.
Key Genes Involved in GO:0046477 glycosylceramide catabolic process
The genes and proteins below are experimentally linked to glycosylceramide metabolism, sphingolipid catabolism, or the signaling lipids produced by GO:0046477.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GCS (glucosylceramide synthase) | Synthesizes glucosylceramide, the substrate class for glycosylceramide catabolism | Defines substrate availability for catabolic enzymes |
| GBA (glucocerebrosidase) | Hydrolyzes glucosylceramide to ceramide and glucose | Model enzyme for glycosylceramide breakdown |
| GBA2 | Beta-glucosidase that degrades glucosylceramide | Non-lysosomal catabolic route for glycosylceramide |
| ASAH1 | Acid ceramidase that converts ceramide to sphingosine | Links glycosylceramide catabolism to sphingoid base signaling |
| SPTLC1 | Serine palmitoyltransferase subunit for sphingolipid synthesis | Controls flux into sphingolipid pools |
| SPTLC2 | Serine palmitoyltransferase subunit | Regulates de novo sphingolipid synthesis |
| CERS2 | Ceramide synthase | Determines ceramide species available for glycosylation |
| UGCG | UDP-glucose ceramide glucosyltransferase | Produces glucosylceramide substrate |
| SMPD1 | Acid sphingomyelinase | Generates ceramide from sphingomyelin, intersecting catabolism |
| SGMS1 | Sphingomyelin synthase | Balances ceramide and sphingomyelin pools |
| SPHK1 | Sphingosine kinase 1 | Produces S1P from sphingosine released by catabolism |
| SPHK2 | Sphingosine kinase 2 | Produces S1P in distinct compartments |
| SGPL1 | Sphingosine-1-phosphate lyase | Irreversibly degrades S1P |
| DES (delta-4 desaturase) | Sphingolipid desaturation for glycosylceramide formation | Plant glycosylceramide pathway |
| Yeast sphingolipid genes | Maintain sphingolipid homeostasis | Yeast models of glycosylceramide metabolism |
| Koji glycosylceramide-related genes | Modify glycosylceramide content in fermented foods | Dietary impact on cholesterol metabolism |
| Microalgal glycoconjugate genes | Produce sterol and sphingoid glycoconjugates | Marine natural product research |
| Ceramide signaling genes | Regulate vascular redox and cardiovascular outcomes | Clinical cardiovascular research |
How Is glycosylceramide catabolic process Regulated?
Glycosylceramide catabolic process is regulated by the availability of substrates and the expression of catabolic enzymes, which are embedded in broader sphingolipid homeostasis. In yeast, sphingolipid metabolism is dynamically controlled and required for normal growth and stress resistance. Sphingolipid signaling and redox regulation are interconnected, so oxidative conditions can influence ceramide and sphingoid base levels. In plants, sphingolipid desaturation is an important metabolic step for glycosylceramide formation, indicating that biosynthetic and catabolic fluxes are coordinated. In mammals, fat-secreted ceramides regulate vascular redox state, showing that systemic metabolic signals influence ceramide pools. Neurodegeneration literature further indicates that ceramide and S1P balance is tightly regulated in the nervous system.
glycosylceramide catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GBA | Neurodegeneration and lysosomal lipid storage | Knockout and point-mutation cell models |
| ASAH1 | Ceramide and sphingosine imbalance in neurodegeneration | Knock-in and overexpression models |
| Ceramide signaling genes | Cardiovascular disease and vascular redox | Knockout models with redox readouts |
| UGCG | Glucosylceramide substrate availability | Overexpression and knockout models |
| Yeast sphingolipid genes | Fermentation and metabolic traits | Yeast knockout and knock-in models |
Cardiovascular disease and vascular redox
Ceramides regulate vascular redox state and influence outcomes in patients with cardiovascular disease. Because glycosylceramide catabolic process releases ceramide, altered flux through this pathway could change the ceramide pool that affects vascular function. Sphingolipid signaling and redox regulation are mechanistically linked, supporting a role for this catabolic process in cardiovascular pathophysiology.
Neurodegeneration
Sphingolipids, with a focus on ceramide and S1P, are implicated in neurodegeneration. Glycosylceramide catabolism contributes to ceramide and sphingosine pools, which in turn affect neuronal stress and survival. Dysregulation of these lipids is therefore a plausible contributor to neurodegenerative processes.
Metabolic and dietary disorders
Koji glycosylceramide commonly contained in Japanese traditional fermented foods alters cholesterol metabolism in obese mice. This suggests that dietary glycosylceramides and their catabolic processing can influence host lipid metabolism. Sake yeast glycosylceramide also modifies flavor and metabolic characteristics, linking microbial glycosylceramide composition to metabolic traits.
From glycosylceramide catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a glycosylceramide hydrolase change ceramide levels? | CRISPR knockout cell model |
| Does a disease-associated point mutation alter catabolic activity? | Point-mutation knock-in model |
| Can a tagged enzyme be used to track glycosylceramide catabolism? | Tagged knock-in model |
| Does overexpression of a catabolic enzyme reduce glycosylceramide storage? | Overexpression model |
| Does dietary glycosylceramide alter cholesterol metabolism? | Mouse metabolic model with glycosylceramide feeding |
| Does sphingolipid desaturation affect glycosylceramide formation? | Plant genetic model such as Physcomitrium patens |
How to Study the glycosylceramide catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS/MS) | Glycosylceramide, ceramide, and sphingoid base levels | Quantifying pathway flux |
| Enzyme activity assay | Hydrolytic cleavage of glycosylceramide | Validating catabolic enzymes |
| CRISPR knockout screening | Gene requirement for glycosylceramide catabolism | Identifying pathway components |
| RNA-seq | Expression of sphingolipid genes | Transcriptional regulation studies |
| Redox assays | Oxidative stress and redox state | Linking ceramide to vascular biology |
| Yeast genetics | Growth and metabolic phenotypes | Sphingolipid homeostasis studies |
| Plant transformation | Glycosylceramide formation and desaturation | Plant sphingolipid research |
| Mouse metabolic phenotyping | Cholesterol and lipid metabolism | Dietary glycosylceramide studies |
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics measures glycosylceramide, ceramide, and sphingoid base species to quantify flux through GO:0046477. This approach is essential for linking enzyme activity to lipid pools in cells and tissues.
Enzyme activity assays
In vitro assays using fluorescent or radiolabeled glycosylceramide substrates measure hydrolytic activity of candidate catabolic enzymes. Such assays help validate whether a gene product directly contributes to glycosylceramide breakdown.
Genetic perturbation and phenotyping
Knockout, knockdown, and overexpression experiments in yeast, plant, and mammalian cells reveal the physiological consequences of altering glycosylceramide catabolism. Yeast models are particularly useful for connecting sphingolipid genes to growth and metabolic traits.
Redox and signaling readouts
Because ceramide and S1P influence redox state, researchers use redox-sensitive probes and signaling assays to test whether glycosylceramide catabolism affects oxidative stress pathways.
How CRISPR Can Be Used to Study GO:0046477 glycosylceramide catabolic process
Knockout
CRISPR knockout of candidate glycosylceramide catabolic genes allows researchers to test whether loss of function alters ceramide and sphingoid base levels. This is a direct way to assign genes to GO:0046477 and to study downstream phenotypes such as redox stress and lipid storage.
Point Mutation
Point-mutation knock-in models can mimic disease-associated variants in catabolic enzymes, enabling assessment of subtle changes in glycosylceramide hydrolysis. Such models are valuable for linking specific mutations to altered ceramide signaling and disease risk.
Knock-in
Tagged knock-in of catabolic enzymes permits localization and interaction studies, helping determine where glycosylceramide breakdown occurs within the cell. This approach supports mechanistic dissection of the pathway in relevant cell types.
Overexpression
Overexpression of glycosylceramide hydrolases can reduce substrate accumulation and increase ceramide production, providing a gain-of-function test of pathway activity. This is useful for validating enzyme function and for engineering lipid profiles.
How EDITGENE Supports glycosylceramide catabolic process Research
Researchers studying glycosylceramide catabolic process-related genes often need to determine whether a candidate gene is causally involved in lipid breakdown, ceramide signaling, or disease phenotypes. EDITGENE provides CRISPR-based cell models and screening services that make these causal tests reproducible and scalable.
Contact EDITGENE today to design your custom CRISPR model for glycosylceramide catabolic process research.
Frequently Asked Questions About glycosylceramide catabolic process
What is glycosylceramide catabolic process?
It is the biological process GO:0046477, defined as the chemical reactions and pathways resulting in the breakdown of glycosylceramides, which are compounds formed by replacement of the glycosidic hydroxyl group of a cyclic monosaccharide by a ceramide group.
What is the GO ID for glycosylceramide catabolic process?
The GO ID is GO:0046477, a biological_process term with synonyms glycosylceramide breakdown, glycosylceramide catabolism, and glycosylceramide degradation.
What genes are involved in glycosylceramide catabolic process?
Genes involved include glucosylceramide synthase, glucocerebrosidase, GBA2, ASAH1, and other sphingolipid enzymes that control ceramide and sphingoid base levels.
Why is glycosylceramide catabolism important in cardiovascular disease?
Ceramides regulate vascular redox state and influence outcomes in patients with cardiovascular disease, so pathways that release ceramide are mechanistically relevant.
How is glycosylceramide catabolic process linked to neurodegeneration?
Ceramide and S1P balance is implicated in neurodegeneration, and glycosylceramide catabolism contributes to these lipid pools.
Do dietary glycosylceramides affect metabolism?
Koji glycosylceramide from traditional fermented foods alters cholesterol metabolism in obese mice, indicating a dietary link.
Which organisms are used to study glycosylceramide catabolism?
Yeast, Physcomitrium patens, microalgae, and mammalian cells are used, reflecting the broad distribution of glycosylceramides.
What methods measure glycosylceramide catabolic activity?
Lipidomics, enzyme activity assays, CRISPR knockout screening, RNA-seq, and redox assays are commonly used.
Can CRISPR knockout models study glycosylceramide catabolic genes?
Yes, CRISPR knockout cell models are used to test loss-of-function effects on glycosylceramide breakdown and ceramide signaling.
What is the difference between glycosylceramide catabolism and sphingolipid catabolism?
Glycosylceramide catabolic process is a specific branch of sphingolipid catabolism focused on breakdown of glycosylated ceramides, as defined by GO:0046477.
Conclusion
GO:0046477 glycosylceramide catabolic process is a focused biological process annotation for the breakdown of glycosylated ceramides. It connects carbohydrate and lipid metabolism to the production of bioactive ceramides and sphingoid bases that regulate redox state, cardiovascular outcomes, and neuronal stress responses. Experimental models in yeast, plants, and mammals continue to reveal how this pathway influences metabolism and disease. For researchers, the pathway offers tractable targets for CRISPR knockout, point-mutation, knock-in, and overexpression studies. Combining genetic models with lipidomics and redox readouts will help clarify how glycosylceramide catabolism contributes to health and disease.
References
- 1. Akawi N et al.. 2021. Fat-Secreted Ceramides Regulate Vascular Redox State and Influence Outcomes in Patients With Cardiovascular Disease.. J Am Coll Cardiol 77(20):2494-2513 PMID: 34016263
- 2. Dickson RC et al.. 1999. Yeast sphingolipids.. Biochim Biophys Acta 1426(2):347-57 PMID: 9878820
- 3. Won JS et al.. 2006. Sphingolipid signaling and redox regulation.. Free Radic Biol Med 40(11):1875-88 PMID: 16716889
- 4. Ferdouse J et al.. 2018. Glycosylceramide modifies the flavor and metabolic characteristics of sake yeast.. PeerJ 6:e4768 PMID: 29761062
- 5. Hamajima H et al.. 2019. Koji glycosylceramide commonly contained in Japanese traditional fermented foods alters cholesterol metabolism in obese mice.. Biosci Biotechnol Biochem 83(8):1514-1522 PMID: 30595103
- 6. Gömann J et al.. 2021. Sphingolipid Δ4-desaturation is an important metabolic step for glycosylceramide formation in Physcomitrium patens.. J Exp Bot 72(15):5569-5583 PMID: 34111292
- 7. Wang G et al.. 2018. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).. Adv Biol Regul 70:51-64 PMID: 30287225
- 8. Stonik VA et al.. 2018. Sterol and Sphingoid Glycoconjugates from Microalgae.. Mar Drugs 16(12) PMID: 30563009
